127 related articles for article (PubMed ID: 34324245)
21. Ubiquitin-specific protease 8 is a novel prognostic marker in early-stage lung adenocarcinoma.
Kim Y; Shiba-Ishii A; Nakagawa T; Husni RE; Sakashita S; Takeuchi T; Noguchi M
Pathol Int; 2017 Jun; 67(6):292-301. PubMed ID: 28544031
[TBL] [Abstract][Full Text] [Related]
22. PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1.
Wang M; Liao Q; Zou P
Cancer Biol Ther; 2020 Apr; 21(4):364-371. PubMed ID: 31939714
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
[No Abstract] [Full Text] [Related]
24. Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.
Behera M; Owonikoko TK; Gal AA; Steuer CE; Kim S; Pillai RN; Khuri FR; Ramalingam SS; Sica GL
Clin Lung Cancer; 2016 Sep; 17(5):e57-e64. PubMed ID: 27137345
[TBL] [Abstract][Full Text] [Related]
25. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
[TBL] [Abstract][Full Text] [Related]
26. Oncogene HSPH1 modulated by the rs2280059 genetic variant diminishes EGFR-TKIs efficiency in advanced lung adenocarcinoma.
Li Y; Zhang N; Zhang L; Song Y; Liu J; Yu J; Yang M
Carcinogenesis; 2020 Sep; 41(9):1195-1202. PubMed ID: 32815538
[TBL] [Abstract][Full Text] [Related]
27. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
[TBL] [Abstract][Full Text] [Related]
28. ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target.
Kimura K; Matsumoto S; Harada T; Morii E; Nagatomo I; Shintani Y; Kikuchi A
Cancer Sci; 2020 Mar; 111(3):951-961. PubMed ID: 31925985
[TBL] [Abstract][Full Text] [Related]
29. The clinical and prognostic significance of YWHAZ in non-small-cell lung cancer patients: Immunohistochemical analysis.
Deng Y; Zheng J; Ma J
J Cell Biochem; 2019 Apr; 120(4):6290-6298. PubMed ID: 30378158
[TBL] [Abstract][Full Text] [Related]
30. The increased expression and aberrant methylation of SHC1 in non-small cell lung cancer: Integrative analysis of clinical and bioinformatics databases.
Liang Y; Lei Y; Du M; Liang M; Liu Z; Li X; Gao Y
J Cell Mol Med; 2021 Jul; 25(14):7039-7051. PubMed ID: 34117717
[TBL] [Abstract][Full Text] [Related]
31. [DEPDC1 is Highly Expressed in Lung Adenocarcinoma and Promotes Tumor Cell Proliferation].
Shen J; Xi M
Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):453-460. PubMed ID: 34134185
[TBL] [Abstract][Full Text] [Related]
32. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells.
Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ
J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486
[TBL] [Abstract][Full Text] [Related]
33. Expression profile and prognostic value of SFN in human ovarian cancer.
Hu Y; Zeng Q; Li C; Xie Y
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30926680
[TBL] [Abstract][Full Text] [Related]
34. Heterotopic production of ceruloplasmin by lung adenocarcinoma is significantly correlated with prognosis.
Matsuoka R; Shiba-Ishii A; Nakano N; Togayachi A; Sakashita S; Sato Y; Minami Y; Noguchi M
Lung Cancer; 2018 Apr; 118():97-104. PubMed ID: 29572010
[TBL] [Abstract][Full Text] [Related]
35. Targeting CDC34 E2 ubiquitin conjugating enzyme for lung cancer therapy.
Zhang S; Sun Y
EBioMedicine; 2020 Apr; 54():102718. PubMed ID: 32268269
[No Abstract] [Full Text] [Related]
36. Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells.
Ko PH; Lenka G; Chen YA; Chuang EY; Tsai MH; Sher YP; Lai LC
Int J Oncol; 2020 Jan; 56(1):165-177. PubMed ID: 31789397
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation
Ge C; Zeng B; Li R; Li Z; Fu Q; Wang W; Wang Z; Dong S; Lai Z; Wang Y; Xue Y; Guo J; Di T; Song X
Bioengineered; 2019 Dec; 10(1):425-436. PubMed ID: 31564210
[TBL] [Abstract][Full Text] [Related]
38. Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma.
Zhang Z; Wang A; Sun B; Zhan Z; Chen K; Wang C
J Cardiothorac Surg; 2013 Apr; 8():95. PubMed ID: 23591077
[TBL] [Abstract][Full Text] [Related]
39. Low BIK outside-inside-out interactive inflammation immune-induced transcription-dependent apoptosis through FUT3-PMM2-SQSTM1-SFN-ZNF384.
Huang J; Wang L; Jiang M; Chen Q; Zhang X; Wang Y; Jiang Z; Zhang Z
Immunol Res; 2016 Apr; 64(2):461-9. PubMed ID: 26423071
[TBL] [Abstract][Full Text] [Related]
40. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
